People Spotlight — May 2022

Johnson & Johnson (J&J) announced the appointment of Thibaut Mongon as CEO designate and Paul Ruh as CFO designate of the new future, yet-to-named consumer health company. As previously announced in November 2021, the planned separation would create two firms: the new J&J and the new consumer health company. This leadership transition will occur after completion of the planned separation of the consumer health business that is expected to occur in 2023.

physIQ, a physiology data analytics platform that uses medical-grade wearable devices to continuously monitor patients in decentralized clinical trials and in hospital at-home settings, has appointed two new members to its executive leadership team to accelerate the organization’s commercialization strategy and growth trajectory. John Wilson has been named senior vice president and general manager of life sciences, while Chris Englerth joins the team as vice president of marketing. In his new role, Wilson is will continue to lead customer-facing initiatives to achieve the corporate goals of the physIQ life sciences business. Englerth, who brings almost 25 years of experience in advertising, communications, and marketing predominantly for healthcare and life sciences organizations, will take the lead on all marketing efforts in support of business development and communications with stakeholders and prospective partners.

CSafe Global, a provider of powered, temperature-controlled air-freight containers for pharmaceuticals, has brought on Micki Turner as its chief human resources officer (CHRO). In her new role as CHRO, Turner will be responsible for developing and executing human resource strategy in support of the company’s growth goals, specifically in the areas of succession planning, talent management, diversity and inclusion, change management, organizational and performance management, training and development, and compensation.

Micki Turner

Congenica, a digital health company that enables precision medicine through its diagnostic decision support platform for genomic data, has appointed Tom Barber, PhD, as its chief scientific officer. He will lead the development and delivery of Congenica’s scientific and clinical vision. Dr. Barber has more than twenty years of experience working in the healthcare industry with extensive leadership experience in pharma, life sciences, and healthcare IT.

Entera Bio Ltd., a developer of orally delivered large molecule therapeutics, has appointed Miranda Toledano, one of Entera’s existing board members, as its chief business officer, CFO, and head of corporate strategy, effective immediately. Toledano most recently served as COO, CFO, and director of TRIGR Therapeutics, an oncology-focused, clinical-stage bispecific antibody company acquired by Compass Therapeutics in June 2021.

Selig Group, a global packaging solutions provider, announced that Adam Sheridan will assume the role of president, effective June 1. Sheridan joined the company in 2015 as an advisor to the board, and has held the roles of Selig’s vice president of corporate development and strategy, and executive vice president/general manager, North America. Selig Group’s president and CEO Steve Cassidy will step away from day-to-day activities as company president, while retaining the role of CEO.

Adam Sheridan

Insmed Incorporated, a biopharma company that aims to transform the lives of patients with serious and rare diseases, has appointed Drayton Wise as chief commercial officer. In addition to his current responsibilities leading the company’s global branded amikacin liposome inhalation suspension (ARIKAYCE) franchise and US commercial activities, Wise will assume responsibility for all of Insmed's global commercial functions. He will also serve as a member of Insmed's executive committee.

JSR Life Sciences, LLC announced that Mark W. Womack will serve as the CEO of two of its affiliate companies: KBI Biopharma, a contract development and manufacturing organization (CDMO) specializing in drug development and biologics manufacturing, and Selexis SA, a cell line development provider. Womack will be responsible for the strategic vision, continued growth, and organizational culture of both organizations, which currently includes eight facilities in Europe and the US. He will report to JSR Life Sciences President Tim Lowery.

BioAgilytix Labs, LLC, a contract research organization (CRO) focused on supporting pharma and biotech partners in all phases of drug development, has appointed two new scientific officers. Lynn Kamen and Michelle Miller bring with them more than two decades of experience combined in drug discovery and development, along with and immunology and toxicology.

ACTO, a commercial learning platform for the life science industry, is strengthening its executive management team with two key additions to meet US demand. The company has appointed John Schultz as chief sales officer to lead and rapidly expand the sales team, while Alison Muller has been named CMO. She brings over 25 years of corporate marketing experience, primarily in the business-to-business software space, and has led the marketing function at multi-billion-dollar software companies, including Oracle.